Literature DB >> 17636257

Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions.

Jordan D Dimitrov1, Lubka T Roumenina, Virjinia R Doltchinkova, Nikolina M Mihaylova, Sebastien Lacroix-Desmazes, Srinivas V Kaveri, Tchavdar L Vassilev.   

Abstract

Various pathological processes are accompanied by release of high amounts of free heme into the circulation. We demonstrated by kinetic, thermodynamic, and spectroscopic analyses that antibodies have an intrinsic ability to bind heme. This binding resulted in a decrease in the conformational freedom of the antibody paratopes and in a change in the nature of the noncovalent forces responsible for the antigen binding. The antibodies use the molecular imprint of the heme molecule to interact with an enlarged panel of structurally unrelated epitopes. Upon heme binding, monoclonal as well as pooled immunoglobulin G gained an ability to interact with previously unrecognized bacterial antigens and intact bacteria. IgG-heme complexes had an enhanced ability to trigger complement-mediated bacterial killing. It was also shown that heme, bound to immunoglobulins, acted as a cofactor in redox reactions. The potentiation of the antibacterial activity of IgG after contact with heme may represent a novel and inducible innate-type defense mechanism against invading pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636257     DOI: 10.1074/jbc.M702751200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Cofactor binding and enzymatic activity in an unevolved superfamily of de novo designed 4-helix bundle proteins.

Authors:  Shona C Patel; Luke H Bradley; Sayuri P Jinadasa; Michael H Hecht
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

2.  Cofactor-mediated protein promiscuity.

Authors:  Jordan D Dimitrov; Tchavdar L Vassilev
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

3.  Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.

Authors:  Maxime Lecerf; Tobias Scheel; Anastas D Pashov; Annaelle Jarossay; Delphine Ohayon; Cyril Planchais; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2015-01-06       Impact factor: 5.157

4.  Heme-Exposed Pooled Therapeutic IgG Improves Endotoxemia Survival.

Authors:  Iglika Djoumerska-Alexieva; Lubka T Roumenina; Tsvetanka Stefanova; Tchavdar Vassilev; Jordan D Dimitrov
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

5.  Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.

Authors:  Nicolas S Merle; Anne Grunenwald; Helena Rajaratnam; Viviane Gnemmi; Marie Frimat; Marie-Lucile Figueres; Samantha Knockaert; Sanah Bouzekri; Dominique Charue; Remi Noe; Tania Robe-Rybkine; Marie Le-Hoang; Nathan Brinkman; Thomas Gentinetta; Monika Edler; Sara Petrillo; Emanuela Tolosano; Sylvia Miescher; Sylvain Le Jeune; Pascal Houillier; Sophie Chauvet; Marion Rabant; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Olivier P Blanc-Brude; Lubka T Roumenina
Journal:  JCI Insight       Date:  2018-06-21

6.  Autoimmune reactivity of IgM acquired after oxidation.

Authors:  Jasna Omersel; Ivica Avberšek-Lužnik; Pegi Ahlin Grabnar; Tanja Kveder; Blaž Rozman; Borut Božič
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

7.  Heme interacts with c1q and inhibits the classical complement pathway.

Authors:  Lubka T Roumenina; Maria Radanova; Boris P Atanasov; Krastio T Popov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Véronique Frémeaux-Bacchi; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

8.  Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer's disease.

Authors:  John A McIntyre; Curtis J Ramsey; Bruce D Gitter; Andrew J Saykin; Dawn R Wagenknecht; Paul A Hyslop
Journal:  Autoimmunity       Date:  2015-02-12       Impact factor: 2.815

9.  A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.

Authors:  Jordan D Dimitrov; Cyril Planchais; Tobias Scheel; Delphine Ohayon; Stephane Mesnage; Claudia Berek; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

10.  Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Authors:  Iglika Djoumerska-Alexieva; Lubka Roumenina; Anastas Pashov; Jordan Dimitrov; Maya Hadzhieva; Sandro Lindig; Elisaveta Voynova; Petya Dimitrova; Nina Ivanovska; Clemens Bockmeyer; Zvetanka Stefanova; Catherine Fitting; Markus Bläss; Ralf Claus; Stephan von Gunten; Srini Kaveri; Jean-Marc Cavaillon; Michael Bauer; Tchavdar Vassilev
Journal:  Mol Med       Date:  2016-03-31       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.